β-Catenin Simultaneously Induces Activation of the p53-p21WAF1 Pathway and Overexpression of Cyclin D1 during Squamous Differentiation of Endometrial Carcinoma Cells

American Journal of Pathology

Volumn 164, Issue 5, 2004, Pages 1739-1749

  Saegusa, Makoto ^a,c   Hashimura, Miki ^a   Kuwata, Takeshi ^b   Hamano, Mieko ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE   (Japan)

^c Department of Pathology ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; PROTEIN P21; PROTEIN P53;

ARTICLE; CARCINOMA CELL; CELL AGING; CELL DIFFERENTIATION; ENDOMETRIUM CARCINOMA; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SENESCENCE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 1942501572     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63732-7     Document Type: Article

References (37)

1. Ozawa M, Baribault H, Kemler R: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989, 8:1711-1717
2. Kemler R: From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993, 9:317-321
3. Gumbiner B: Signal transduction by β-catenin. Curr Opin Cell Biol 1997, 7:634-640
4. -/- colon carcinoma. Science 1997, 275:1784-1787
5. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-1790
6. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792
7. He T-C, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler K: Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512
8. Tetsu O, McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426
9. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A: The cyclin D1 gene is a target of the β-cateni/LEF-1 pathway. Proc Natl Acad Sci USA 1999, 96:5522-5527
10. Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JFM, Zhurinsky J, Geiger B, Oren M: Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J 1999, 18:3054-3063
11. Damals A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M: Deregulated β-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J 2001, 17:4912-4922
12. Shtutman M, Zhurinsky J, Oren M, Levina E, Ben-Ze'ev A: PML is a target gene of β-catenin and plakoglobin, and coactivates β-catenin-mediated transcription. Cancer Res 2002. 62:5947-5954
13. Saegusa M, Okayasu I: Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 2001, 194:59-67
14. Saegusa M, Okayasu I: Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas. J Pathol 1997, 182:429-436
15. Saegusa M, Kamata Y, Isono M, Okayasu I: Bcl-2 expression is closely correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas. J Pathol 1996, 180:275-282
16. Saegusa M, Hashimura M, Yoshida T, Okayasu I: β-Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer 2001, 84:209-217
17. Nishida M, Kasahara K, Kaneko M, Iwasaki H: Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynec Jpn 1985, 37:1103-1110
18. WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Cancer Res 2001, 61:7754-7762
19. Sherman ME, Bur ME, Kurman RJ: p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995, 26:1268-1274
20. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L: p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997, 150:177-185
21. Saegusa M, Okayasu I: Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings. J Cancer Res Clin Oncol 1997, 123:429-434
22. Baas IO, Mulder J-WR, Offerhaus JA, Vogelstein B, Hamilton SR: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994, 172:5-12
23. Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R, Garcia-Rostan G, Prat J, Guo M, Herman JG, Matias-Guiu X, Esteller M, Palacios J: Abnormalities of the APC/β-catenin pathway in endometrial cancer. Oncogene 2002, 21:7981-7990
24. Saegusa M, Hamano M, Kuwata T, Yoshida T, Hashimura M, Akino F, Watanabe J, Kuramoto H, Okayasu I: Up-regulation and nuclear localization of β-catenin in endometrial carcinoma in response to progesterone therapy. Cancer Sci 2003, 94:103-111
25. Schlosshauer PW, Pirog EC, Levine RL, Ellenson LH: Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma. Mod Pathol 2000, 13:1006-1071
26. Kirchner T, Muller S, Hattori T, Mukaisyo K, Papadopoulos T, Brabletz T, Jung A: Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virchows Arch 2001, 439:512-522
27. Kirchner T, Brabletz T: Patterning and nuclear β-catenin expression in the colonic adenoma-carcinoma sequence: analogies with embryonic gastrulation. Am J Pathol 2000, 157:1113-1121
28. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T: Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001, 98:10356-10361
29. Miyoshi K, Shillingford JM, Le Provost F, Gounari F, Bronson R, von Boehmer H, Taketo MM, Cardiff RD, Hennighausen L, Khazaie K: Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epithermis and squamous metaplasias. Proc Natl Acad Sci USA 2002, 99:219-224
30. Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD, Hennighausen L: Activation of different Wnt/β-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 2002, 21:5548-5556
31. Saegusa M, Okayasu I: Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. Cancer 1998, 83:111-121
32. Robertson K, Jones PA: The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol 1998, 18:6457-6473
33. Sadot E, Geiger B, Oren M, Ben-Ze'ev A: Down-regulation of β-catenin by activated p53. Mol Cell Biol 2001, 21:6768-6781
34. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993, 7:1559-1571
35. INK4A and is a region of low proliferation. Am J Pathol 2001, 159:1613-1617
36. Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W, Pandolfi PP: The function of PML in p53-dependent apoptosis. Nat Cell Biol 2000, 2:730-736
37. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C, Sal GD: Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 2000, 19:6185-6195